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1. Introduction 
“Seeing is believing.” This may not be true in all areas of biomedical research, but 
identifying cellular characteristics of tumors and specifying their anatomical locations are 
the most important processes for diagnosing and treating tumors. Furthermore, various 
imaging techniques with various modalities have been introduced to investigate disease 
progression, track the pharmacokinetic behavior of drugs, and in clinical applications. 
Reconstructing images at the molecular level has been realized with the dramatic 
advancement in energy sources, detectors, computational methods, and instruments. 
Computed tomography (CT), magnetic resonance imaging (MRI), positron emission 
tomography (PET), and ultrasound imaging are well-known imaging techniques that have 
tremendously improved not only preclinical research but also clinical treatment. Contrast-
enhanced CT, MRI and PET have permitted non-invasive detection of abnormal tissues, 
particularly for tumor research and clinical applications.  
Imaging techniques currently used for brain tumor research vary with purpose and imaging 
characteristics. The techniques can be grouped by three aspects: (1) energy, (2) spatial 
resolution, and (3) type of information obtained (Weissleder & Pittet, 2008). The energies 
generally used for these techniques are X-rays (e.g., classic X-ray imaging, CT, multi-
detector CT), magnetic fields (e.g., MRI and diffusion MRI), positrons (e.g., PET), sound 
waves (e.g., ultrasound imaging, interventional ultrasound imaging), photons (e.g., 
bioluminescence imaging, fluorescence reflectance imaging, fluorescence-mediated 
tomography, and laser scanning microscopy imaging), and combinations of such modalities 
(e.g., PET-CT, PET-MRI, CT, or MRI with fluorescence-mediated tomography). The 
techniques can also be distinguished by spatial resolution and the information obtained: (1) 
macroscopic, (2) mesoscopic, and (3) microscopic or (1) anatomical, (2) physiological, and (3) 
cellular and molecular. 
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Optical imaging techniques (OITs) are a subset of imaging modalities that mainly use 
photons as their energy source. The beauty of these techniques is that the cellular or 
molecular level of the target can be visualized and target location or texture can be 
identified with different dyes (Kovar et al., 2007; Massoud & Gambhir, 2003). Although OITs 
have limited imaging depth and procedure accessibility, they have become indispensable in 
many fields of research and clinical applications, including brain tumor research. 
2. OITs for brain tumor research 
Tremendous technological improvements and an increase in the number of OIT applications 
have occurred with advances in optics and probes. Visualization of the structures and 
functions of the brain has become possible with microscopic and macroscopic imaging 
techniques. Because of these advances, OITs have been actively utilized in the field of brain 
research. 
Ultraviolet, visible, and infrared light are the main spectrums of the light used in OITs. The 
energy (E) of photons is denoted by wavelength (┣). Photons with a shorter wavelength 
have higher energy than those with a longer wavelength, which is given by the following 
equation: 
hc
E = ┣  
where h is Planck’s constant and c is the speed of light. 
 
Spectrum 
Spatial 
resolution 
Visible light 
 (380-780nm) 
Near-infrared 
(650-1400nm) 
Macroscopic Bioluminescence imaging (BLI) Near-infrared fluorescence (NIRF) 
imaging 
Microscopic Confocal laser scanning microscopy 
(CLSM) imaging 
Multi-photon laser scanning 
microscopy (MPLSM) imaging 
Table 1. Frequently used optical imaging techniques for in vivo studies 
Although tissue penetration by photons varies with the type of tissue, longer wavelength 
light generally penetrates deeper; less than 1 mm at 400 nm (blue), 0.5 to 2 mm at 514 nm 
(green), 1 to 6 mm at 630 nm (red), and 1 to 2 cm at 800 nm (near-infrared) (Barolet, 2008; 
Kalka et al., 2000; Wilson & Patterson, 1986). Penetration depth for a human brain tumor 
was reported to be 1 mm at 514 nm, 2.5 mm at 635 nm, and 6 mm at 1060 nm (Svaasand & 
Ellingsen, 1985). 
Spatial resolution and the biological level of information should also be considered for 
imaging. The primary macroscopic imaging information is physiological, cellular, and 
molecular, and screening of molecular events or cell tracking is possible with OITs. Higher 
resolution images to obtain anatomical and quantitative information can be attained with 
microscopic imaging. But both macroscopic and microscopic imaging have depth and 
coverage limitations, which are regulated by the chosen wavelength and fluorophore 
(Wiesner et al., 2009).  
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Fig. 1. Schematization of the most frequently used optical imaging techniques for in vivo 
studies. The bar in the middle indicates the light spectrum.  
The most frequently used OITs for in vivo brain tumor studies are bioluminescence imaging 
(BLI), near-infrared fluorescence (NIRF) imaging, confocal laser scanning microscopy 
(CLSM) imaging, and multi-photon laser scanning microscopy (MPLSM) imaging (Table 1 
and Fig. 1). These OITs are categorized by light spectrum and spatial resolution. Using a 
particular technique is determined by the needs and purposes of the research and by 
considering the technique characteristics (Table 2). 
2.1 BLI 
BLI is a non-invasive macroscopic imaging technique that uses luminescence for imaging. 
The chemical reaction between luciferase and luciferin (d-(-)-2-(60-hydroxy-20-
benzothiazolyl)-thiazone-4-carboxylic acid) in the presence of oxygen and adenosine 
triphosphate transforms chemical energy into luminescence at a wavelength of 560 nm. 
Cells engineered to express luciferase emit light in the presence of luciferin (Ozawa & James, 
2010; Sun et al., 2010).  
A luciferin substrate is administered via an intraperitoneal injection, and images obtained 10 
to 20 minutes after injection for tumor imaging in luciferase-expressing tumor xenograft 
models. The beauty of this technique is not only that it is non-invasive and rapid but that it 
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is highly sensitive, because there is no inherent light background noise (Wiesner et al., 2009). 
Tumor development, growth, and location can be quantitatively and noninvasively 
analyzed with BLI (Rehemtulla et al., 2000).  
Although BLI has many benefits, there are several drawbacks. The transmission efficiency of 
bioluminescence largely depends on the type of tissue and the depth of origin, due to the 
scattering properties of visible light. Disturbances in the light transmission due to light 
absorption by hemoglobin and signal attenuation by melanin and fur also limit application 
of BLI (O'Neill et al., 2010). Additionally, even though advances have been made to translate 
BLI data into three-dimensional (3D) tomographic imaging (Chaudhari et al., 2005; Slavine 
et al., 2006), commonly used BLI has limited use for 3D reconstruction.  
 
Technique Resolution Depth Time Imaging agent References 
BLI Several 
mm 
cm Minutes Luciferin (O'Neill et al., 
2010; Rehemtulla 
et al., 2000; Sun et 
al., 2010) 
NIRF Several 
hundred 
┤m 
cm Minutes Near-infrared 
fluorophore 
(Choi et al., 2011; 
Kircher et al., 2003; 
Veiseh et al., 2007) 
CLSM 0.5-1.0 ┤m < 100-200 
┤m 
Second to 
hours 
Fluorophore, 
photoprotein 
(Centonze & 
White, 1998; 
Gratton, 2011) 
MPLSM 0.5-1.0 ┤m < 500-1,000 
┤m 
Second to 
hours 
Fluorophore, 
photoprotein 
(Calabrese et al., 
2007; Farrar et al., 
2010; Levene et al., 
2004; Theer et al., 
2003; Winkler et 
al., 2009; Winkler 
et al., 2004) 
Table 2. Overview of optical imaging techniques for in vivo studies 
2.2 NIRF imaging 
NIRF imaging is an efficient, non-invasive, and high-throughput modality useful for in vivo 
imaging (Hsu et al., 2006). NIRF imaging uses near-infrared fluorophores, whether the 
reflectance technique is applied or not. Because NIRF (650–900 nm) penetrates deeper into 
tissue than luminescence (Shah & Weissleder, 2005) and does not require cellular 
transfection, NIRF imaging is regarded as a more effective technique for brain tumor studies 
than that of BLI. 
However, because data acquisition is based on a two-dimensional planar image, NIRF 
imaging is limited for 3D reconstruction. Additionally, NIRF imaging has problems of light 
scattering and low quantum efficiency, due to longer wavelengths, which leads to lower 
signal intensity (Amiot et al., 2008). Although NIRF penetrates deeper than BLI (up to 
several centimeters), the depth is not adequate to analyze deeper targets within a large 
animal. Thus, at present, this imaging modality, which uses traditional NIRF fluorophores, 
is suitable only for small animals such as rodents. 
Currently used NIRF materials are fluorescent dyes, quantum dots, single-walled carbon 
nanotubes, and rare earth metal reagents (Amiot et al., 2008). Because such fluorophores do 
not have specific targets, molecular modifications are required to specify targets. Specificity 
is achieved by combining targeting molecules with fluorophores such as Cy5.5-chlorotoxin 
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(Veiseh et al., 2007). Vascular leakiness can be utilized for brain tumor imaging. Indocyanine 
green (ICG), an NIR fluorophore, has been used to analyze blood perfusion and 
permeability of tumors (Choi et al., 2011). Most ICG is bound to albumin in serum, so it does 
not normally leak into the extravascular space, but it does pass into highly leaky tumor 
vasculature. Rapid vascular normalization with neutralizing vascular endothelial growth 
factor was identified with this novel dynamic fluorescence imaging technique using ICG. 
2.3 Laser scanning microscopy (LSM) imaging 
Since CLSM was introduced in the late 1980s (Brakenhoff et al., 1985; Centonze & White, 
1998), the acquisition of high resolution sectional imaging data has become practical, even 
with thick samples. CLSM collects information from selected foci using a pin-hole, which 
eliminates out-of-focus information. Phototoxicity in the area that is not the region of 
interest (ROI) and short penetration depth are major limitations of this technology.  
MPLSM is a revolutionized fluorescence microscopy modality that uses non-linear optical 
properties such as multi-photon absorption. Near-infrared light, which is delivered with a 
high-power femtosecond pulse, excites fluorophores or molecules in a small specific spot 
with longer wavelength light (Gratton, 2011). MPLSM has been applied to intra-vital studies 
since the discovery of molecular excitation by simultaneous absorption of two photons 
(Denk et al., 1990). 
Because MPLSM utilizes longer wavelength photons, image information can be acquired 
with minimal phototoxicity to the samples and with deeper penetration compared with 
conventional CLSM. Up to 800–1,000 ┤m depth resolution is achievable with an MPLSM 
system (Theer et al., 2003; Weissleder & Pittet, 2008), but typically < 500 ┤m depth of 
resolution is achievable for brain imaging (Levene et al., 2004).  
However, it remains technically challenging, as significant decreases in resolution occur at 
greater depths. So, these techniques are inappropriate for deep tissue (> 1 cm depth) 
imaging. Furthermore, samples or specimens must be prepared with more invasive methods 
for in vivo brain tumor imaging, such as the dorsal skin-flap chamber or cranial window 
methods, as compared with BLI or NIRF imaging. Although lower energy photons are 
transmitted into the sample than with BLI or NIRF, fluorophore photo-bleaching frequently 
occurs, particularly with repetition. 
3. Animal models for brain tumor research 
In vivo animal model studies are very important for translating biological assessments. 
Many methods and techniques are available to create animal models that mimic the 
pathology and tumor environment of a human brain tumor. The tumor model type is 
chosen depending on the experimental conditions and study purposes. 
The xenograft tumor model (XM) is one of the most common and powerful methods to 
mimic tumor status. XM has been widely used for interventional studies due to 
convenience. However, the genetically engineered mouse model (GEMM) is preferred for 
results because of the difference between cell origin and an inability to represent the 
mechanism of tumor development. However, difficulty producing the model, late onset, 
insufficient representation of the evolving microenvironment with additional stochastic 
genetic events, and the inherent difficulty of tumor diagnosis in a timely fashion makes 
GEMM less desirable (de Vries et al., 2010; Huse & Holland, 2009). Table 3 is an overview of 
the animal models currently used for brain tumor studies. 
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Type Subtype Realization Lead 
time 
Relevance Imagi
ng 
techni
que 
used 
References 
Genetically 
engineered 
mouse 
model 
(GEMM) 
Germline 
modification 
Highly 
difficult 
Several 
months 
to years 
High BLI, 
NIRF 
(Fomchenko & 
Holland, 2006; 
Huse & 
Holland, 2009) 
Somatic cell 
gene 
transfer 
Difficult Weeks 
to 
months 
Intermedate 
 to high 
BLI, 
NIRF 
(de Vries et al., 
2010; Wiesner 
et al., 2009) 
Xenograft 
tumor 
model (XM) 
Subcutaneou
s transplant 
Easy Weeks 
to 
months 
Low BLI, 
NIRF 
(Choi et al., 
2011; O'Neill 
et al., 2010) 
Dorsal skin 
flap 
chamber 
Intermediate Several 
weeks 
Low LSM (Hoffman, 
2002; Tozer et 
al., 2005) 
Orthotopic, 
non-cranial 
window 
Intermediate Several 
weeks 
Intermediate BLI, 
NIRF 
(Hashizume et 
al., 2010; 
Ozawa & 
James, 2010; 
Szentirmai et 
al., 2008) 
Orthotopic-
cranial 
window 
Difficult Several 
weeks 
Intermediate LSM (Calabrese et 
al., 2007; 
Farrar et al., 
2010; Winkler 
et al., 2009; 
Winkler et al., 
2004) 
Table 3. Overview of animal models for brain tumor research (“imaging technique used” are 
those mainly used for in vivo imaging) 
3.1 GEMM 
GEMM is a tumor model generated by a particular genetic alteration. GEMM strongly 
recapitulates the tumorigenesis process and the nature of tumor progression. Thus, 
scientists appreciate the results that are obtained from this model. However, many GEMM 
express unexpected alterations in genes of other organs or tissues. In those cases, it is 
difficult to say whether GEMM fully presents tumorigenesis, so it is referred to as human 
cancer predisposition syndromes (Fomchenko & Holland, 2006). Because modifying a 
particular gene and achieving the target phenotype are very difficult to realize, this model is 
the first choice for an initial study. 
 GEMM includes transgene, knock-out, and knock-in mouse models. A transgenic mouse 
model contains additional genes for a certain purpose (Hanahan et al., 2007). A knock-out 
mouse model has one or more specific genes inactivated mainly by replacing or disrupting 
the coding exons, whereas a knock-in mouse model is one in which an endogenous 
sequence is exchanged with a mutated DNA sequence without disrupting any other genes 
(Manis, 2007). 
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There are many types of GEMMs that refer to brain tumors. These models mainly focus on 
gliomas and medulloblastomas, which are the most common brain tumors in humans. The 
main considerations for producing such models are as follows: genetics, tumorigenesis 
mechanism of the model (conventional and/or conditional, transgenic and/or knock-out), 
incidence of successful tumor development, histological or morphological grades (Huse & 
Holland, 2009), development type (de novo or progressive) (Kwon et al., 2008), the possibility 
of recapitulation, and organ or area specificity (Huse & Holland, 2010). 
Advances have been made in production methods to overcome the inconveniences and 
uncertainties of traditional GEMM, which are derived from germline modification 
strategies. Somatic cell gene transfer is a method that generates a genetically altered tumor 
using viral or pegylated DNA plasmids. While traditional GEMM is used to spontaneously 
develop a tumor in any location, the somatic cell gene transfer model forces the alteration to 
a specific location, which is very important for imaging. 
For example, de Vries et al. developed a high-grade glioma model using a stereotactic 
intracranial injection of lentiviral GFAP-Cre or CMV-Cre vectors into compound LoxP-
conditional mice, p53;Ink4a/Arf;K-Rasv12 (de Vries et al., 2010). The mice developed a tumor 
within 25 days after injection. They obtained information about the existence of the tumor at 
an early stage using BLI. They also provided evidence for therapeutic interventional studies 
by comparing the alterations and differences in tumor growth between a control and a 
chemotherapy treatment group using longitudinal BLI analysis. 
Although somatic cell gene transfer models can predict tumor location, the tumor usually 
originates in a deep brain structure. Therefore, the OITs are limited to BLI or NIRF imaging. 
It is affordable to use LSM imaging for GEMM; however, LSM imaging is mostly limited to 
sample slice imaging and is insufficient for in vivo studies. 
3.2 XM 
As mentioned previously, XM is the most frequently used model for in vivo tumor studies. 
The XM is created by implanting an established cell line or primary tumor cells into a 
particular location in the animal. The strengths and weaknesses of this technique are listed 
in Table 4 (Finkelstein et al., 1994; Fomchenko & Holland, 2006).  
 
Strengths Weaknesses 
 Synchrony and reproducibility of tumor 
formation 
 Rapid tumor development 
 High penetrance 
 Easy tumor visualization 
 Lack of stepwise genetic alteration 
 Alteration of the cells or cell line 
 Lack of histological accurate 
vascularization 
 Rare recapitulation of tumor-of-origin 
phenotype 
Table 4. Strengths and weaknesses of the xenograft tumor model 
The frequently used types of XM models for brain tumor studies can be summarized as 
follows: (1) subcutaneous transplant model, (2) dorsal skin-flap chamber model, (3) 
orthotopic, non-cranial window model, and (4) orthotopic-cranial window model. OITs can 
be used with these models, because of convenience and ability to specify the ROI.  
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3.2.1 Subcutaneous transplant model 
The subcutaneous transplant model is simply made by injecting a tumor cell suspension in 
the flank or leg area of the animal. Tumor growth progression differs depending on cell 
characteristics but usually it takes several weeks to months to reach an adequate volume for 
study (Morton & Houghton, 2007). Usually 3 × 106–1 × 107 cells are needed for a successful 
implantation. 
Interventional studies were classically performed by estimating tumor volume using direct 
length and width measurements (Jensen et al., 2008) or histopathological analysis such as 
immunohistochemistry. However, these estimates only provide relative values and are 
inherently biased, whereas histopathology can only be performed by excising the tumor. 
Because BLI and NIRF imaging provide non-invasive and semi-quantitative measurements, 
OITs have become a useful modality for longitudinal in vivo studies using this model. 
In addition to quantifying tumor mass, an OIT modality can be used to measure functional 
vascular parameters (Choi et al., 2011). Vascular heterogeneity, density, and permeability of 
an implanted tumor can be estimated with a quantitative analysis of emitted signal 
intensity. 
3.2.2 Dorsal skin-flap chamber model 
Longitudinal in vivo optical studies are possible with minimal intervention if localized 
surgical implantation of the tumor is supported by fixing a transparent slide glass coverslip, 
such as in the dorsal skin-flap chamber (DSFC) model. More detailed and precise 
information can be obtained with the use of the LSM technique. Because MPLSM imaging 
has minimal phototoxicity and deeper penetration than some other modalities, minimally 
invasive and repetitive images are achievable with high resolution.  
Using the LSM technique, the DSFC tumor model not only provides information about the 
tumor itself but also of the interaction between the tumor and tumor-associated vessels. 
Parameters such as inter-capillary distance, vessel length, and branching ratios can be 
analyzed (Tozer et al., 2005). Furthermore, 3D data facilitates a precise evaluation of tumor 
angiogenesis. 
Implantation of the tumor is possible by either locating a tumor fragment or spheroid just 
above the upper tissue layer (Torres Filho et al., 1995) or by injecting a suspension of tumor 
cells above the fascia. The total cell count of the initial implantation is not fixed, and location 
and method of implantation can be varied depending on the study group. Regardless of 
which protocol is used, images can be acquired several weeks after injection. 
3.2.3 Orthotopic, non-cranial window model 
The orthotopic xenograft model offers more advanced synchrony of the brain tumor 
microenvironment than that of the subcutaneous transplant or DSFC models. Generally, a 
tumor is implanted with an inoculating cell line suspension containing 1 × 105–5 × 105 cells 
by stereotactic injection. Injection location varies among research groups. For example, 
implantation by Ozawa and James was 2 mm lateral to the bregma, 1 mm anterior to the 
coronal suture, and at a 3 mm depth from the underside of the skull (Ozawa & James, 2010); 
Hashizume et al. utilized an implantation protocol of 3 mm from the midline, just behind 
the bregma for supratentorial, and 3 mm from the midline, 1.5 mm behind the lambdoid 
suture for infratentorial, with a 3 mm depth from the bottom of the skull (Hashizume et al., 
2010); and Szentirmai et al. performed surgery at 2.5 mm lateral and 0.5 mm posterior to the 
bregma and at a parenchymal depth of 3.5 mm (Szentirmai et al., 2008). 
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Implantation in deeper locations provides sufficient space and abundant vascular support 
for tumor growth but precludes intravital microscopic imaging. Early detection and time-
series quantitative estimation of tumor growth are possible using BLI and NIRF imaging 
techniques. 
3.2.4 Orthotopic-cranial window model 
The orthotopic-cranial window model combines the benefits of window modeling, which 
enables microscopic evaluation, with the synchrony of an orthotopic xenograft. Complexity 
of realization is a drawback of this technique compared with other previously described 
xenograft models, but it is not as much as with GEMM. Researchers can efficiently achieve a 
model within several weeks with practice.  
The tumor can be implanted by fragment or with a cell suspension. However, implantation 
methods vary between research groups, as compared to the non-cranial window model. We 
consider that the differences are mainly due to variations in the cranial window surgery 
method.  
For example, Winker et al. attained the model by implanting 0.2–0.3 mm size tumor 
fragments at a depth of 0.4 mm (Winkler et al., 2004), whereas Farrar et al. injected 3 x 106–2 
x 107 suspended cells at a depth of 1.75 mm with a 55° angle (Farrar et al., 2010). We believe 
that injecting a cell suspension volume of 3–5 ┤l containing 1 x 105–5 x 105 cells (Winkler et 
al., 2009) or up to 1 x 106 cells (Calabrese et al., 2007) at a depth of 0.5–2.0 mm from the 
bottom of the skull is adequate.  
Theoretically, all OITs are applicable with this model, if cells and materials are properly 
prepared; however, MPLSM imaging is the first choice.  
3.3 Metastatic brain tumor models 
The brain tumor models discussed above are models for recapitulating primary or 
secondary brain tumors originating within the brain. Although most studies of primary and 
secondary brain tumors are ongoing, metastatic brain tumor studies are also conducted, 
because metastatic brain tumors have the highest incidence among all brain tumors. The XM 
is clearly more relevant to the metastatic process; therefore, model production methods are 
metaphysically the same as XMs. 
A metastatic model can be produced by an entrancing method, as reported by Kienast et al. 
They realized a metastatic brain tumor model by injecting tumor cells via the carotid artery 
and demonstrated metastasis formation with MPLSM imaging and a cranial window 
(Kienast et al., 2010). Such a study was an excellent demonstration of how MPLSM imaging 
can be combined with the cranial window model.  
4. Application of chronic cranial window model system with CLSM and 
TPLSM imaging for brain tumor research 
An Orthotopic xenograft of a brain tumor with a cranial window system has emerged as a 
potent technique for brain tumor research because it is less costly and requires less lead time 
to manufacture an XM than a primary tumor model, and the researcher can select the ROI to 
perform the analysis in a time-dependent manner.  
Thinned skull and open craniotomy (craniectomy) models are two types of cranial window 
systems. The main considerations relating to the two systems are invasiveness (Xu et al., 
2007), feasible imaging depth, and maintenance duration of the window. Drew et al. 
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reported that chronic observations are possible with the thinned skull cranial window 
model (Drew et al., 2010). However, the thinned skull model can only be applied for 
metastatic brain tumor model which is created by intracardiac injection of metastatic tumor 
cells, or for some GEM brain tumor model which produces a tumor at the superficial cortical 
area. An open craniotomy is more suitable for LSM imaging of an orthotopic xenograft, 
regardless of whether dura matter must be removed (Orringer et al., 2010) 
Now, we will introduce our xenograft model method, which we named the orthotopic 
xenograft-chronic cranial window (OxCCW) model. This model is based on previous studies 
and reports (Calabrese et al., 2007; Farrar et al., 2010; Winkler et al., 2009; Winkler et al., 
2004). The OxCCW model preserves dura mater for avoidance of additional brain injury, 
convenience and a high success rate. The resulting images are obtained with CLSM and 
MPLSM imaging techniques. 
4.1 OxCCW model 
Red fluorescence protein (RFP) and green fluorescence protein (GFP) expressing U251 
(U251-RFP and U251-GFP) tumor cells (human malignant glioma cell-line) were grown in 
vitro in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum, 1% 
non-essential amino acids, and 1% penicillin-streptomycin at 37°C under 20% O2 and 5% 
CO2. After harvesting, the cells were resuspended in serum-free DMEM medium for 
implantation into immunodeficient mice. The mouse head was fixed in a stereotactic frame. 
After the skin incision, a craniotomy was performed at the temporo-parietal area with a 
high-speed drill. A modified micropipette was introduced into a small incision in the dura 
at the trajectory point for the injection. In total, 2 x 105 cells in a 5 ┤l volume were injected at 
a depth of 0.5 mm from the bottom of the skull. After injection, the craniotomy area was 
covered with a slide glass coverslip and fixed with bone cement (Fig. 2). 
 
 
Fig. 2. Macroscopic inspection of orthotopic xenograft-chronic cranial window (OxCCW) 
model. A. 10X image. The cranial window was set at the left temporo-parietal area. B. 20X 
image. The slide glass coverslip was tightly fixed with bone cement. Pial vascular structures 
could be identified. 
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4.2 CLSM and MPLSM imaging of OxCCW 
Time-series images using CLSM and MPLSM can be captured with the OxCCW model. 
CLSM images were obtained with 488 nm and 543 nm lasers, and MPLSM images were 
obtained with an 800 nm femtosecond pulsed laser. The growth and progression of the 
implanted tumor and vascular co-option processes were readily monitored. Vascular 
changes due to surgical injury (i.e., engorgement of superficial vessels), which were 
inevitable due to implantation, usually recovered within 1 week after the surgery (Fig. 3). 
Acquisition of acceptable CLSM images was limited to a depth of 100 ┤m in our OxCCW 
model. Imaging of an area deeper than 100 ┤m was not impossible, but deeper depths 
revealed poorer resolution, and photo-induced injury occurred more frequently due to a 
need for more laser power. This problem with CLSM imaging can be solved with MPLSM 
imaging (Fig. 4). Theoretically, imaging to a depth of 500–1,000 ┤m is possible with MPLSM. 
In our experience, acceptable imaging depth of the OxCCW model was extended up to 300 
┤m from the pial surface using MPLSM imaging.  
 
 
 
 
 
 
 
 
 
Fig. 3. Time-series confocal laser scanning microscopy images of the orthotopic xenograft-
chronic cranial window (OxCCW) model. The images above are projections from the pial 
surface to a depth of 100 ┤m. In total, 2 x 105 U251-RFP cells were implanted 1 week before 
initial imaging. FITC-dextran (2 MDa) was intravenously injected for vascular imaging. (A, 
B) Tumor progression with the vascular co-option could be monitored with the imaging 
system. Red indicates emitted fluorescence from U251-RFP cells, and green indicates FITC-
dextran. The interval between A and B was 1 week. Scale bar, 100 ┤m. 
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Fig. 4. Comparative confocal and multi-photon laser scanning microscopy images with the 
orthotopic xenograft-chronic cranial window model. In total, 2 x 105 U251-GFP cells were 
implanted 1 week before imaging. Rhodamin-dextran (70 kDa) was intravenously injected 
for vascular imaging. The imaging information was collected from a depth of 100–150 ┤m 
from the pial surface. Green indicates emitted fluorescence from U251-GFP cells and red 
indicates rhodamin-dextran. (A) Projection image from a confocal laser scanning 
microscope. (B) Projection image from a multi-photon laser scanning microscope. Scale bar, 
100 ┤m. 
5. Future perspectives  
OIT applications are now beyond imaging itself and are not restricted by experimental 
boundaries. Intra-operative brain tumor imaging, to define the tumor area for resection, has 
already been applied in clinical settings. Fluorescence-guided surgical resection has been 
performed in an operating room using 5-aminolevulinic acid (5-ALA), a prodrug of 
fluorescent molecule protoporphyrin IX (PpIX), and useful statistical results were obtained 
(Stummer et al., 2006). In addition to the clinical application of OITs for diagnostic purposes, 
many attempts have been made to introduce therapeutic applications of OITs such as 
photodynamic therapy. 
Combining optical technologies with OITs has been actively attempted for biomedical 
applications other than imaging. Our group recently reported utilizing a near-infrared 
femtosecond laser for minimally invasive molecular delivery into the brain (Choi et al. 
2011). The delivery is acquired by optical modulation, which enhances the transient increase 
in vascular permeability (Fig. 5). Additionally, optical modulation of neurovascular 
coupling in combination with label-free optical activation of astrocytes was also 
demonstrated. 
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Fig. 5. Laser-induced vascular permeabilization. Imaging and optical modulation were 
performed with multi-photon laser scanning microscopy (800 nm, femtosecond pulsed 
laser). FITC-dextran (2 MDa) and fluorescent microspheres (FS03F/5147, Bangs 
Laboratories) were injected via the tail vein. Green and red indicate FITC-dextran and 
fluorescent microspheres, respectively. (A) Pre-permeabilization image. (B) Post-
permeabilization image. Green dye (white arrows) and red fluorescent microspheres (white 
arrowheads) were extravasated after optical modulation. Red dot indicates the region that 
was optically modulated. White dotted line demarcates baseline lumen of the venule. Scale 
bar, 50 ┤m. 
6. Conclusion 
OITs have emerged as essential tools for intravital imaging. The most frequently used OITs 
are BLI, NIRF, and LSM imaging. Among them, MPLSM is the most potent imaging 
technique because it obtains precise intravital microscopic information. Translational and 
interventional studies are expected to be performed in a more efficient manner with the 
combination of MPLSM and the OxCCW system. 
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